Redmile Group’s Attovia Therapeutics ATTO Stock Holding History
Bought
Maintained
Sold
Other funds holding ATTO
Redmile Group's ATTO Position: Q3 2026 in Review
Redmile Group opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 1,163,587 shares worth $19.9M. The stake represents 1.46% of the portfolio and ranks #15 among its holdings.
57 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.
- Redmile Group held 1,163,587 shares of Attovia Therapeutics worth $19.9M as of Q3 2026.
- Attovia Therapeutics was a new Redmile Group position in Q3 2026.
- Attovia Therapeutics made up 1.46% of Redmile Group's portfolio in Q3 2026, its #15 holding.
- 57 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.
Based on Redmile Group's 13F filing for Q3 2026, filed 16 Nov 2026.